AsepticSure™

Medizone International, Inc.  (MZEI.OB) Medizone International, Inc. is a research and development company engaged in developing  AsepticSure™ System to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures.

The AsepticSure™ hospital sterilization system is a portable, affordable, easily operated system that can be used by trained maintenance staff.  It is placed in the center of the room to be cleaned.  Vents and doors are then sealed with an easily and cleanly removable 3M-tape product.

The AsepticSure™ equipment is turned on from outside of the room through a remote wireless computer interface.  The room is filled with a unique and patented gas formula that is ozone (O3) based to specific humidity and charge strength.  Following the charge period the sterilization process is remotely turned off and a separate technology is employed that restores the atmosphere inside the room to EPA standards.

The entire process, start to finish, takes 80 to 90 minutes at which time the room will have been cleared of pathogens to the 6 log sterilization standard. The room is opened and the equipment is then ready to move on to the next space to be treated, leaving the treated room sterile of pathogens with a fresh, oxygen (O2) freshness.

Current research is being conducted at Medizone’s dedicated laboratories located in Innovation Park, Queen’s University in Kingston, Ontario, Canada, under the direction of Dr. Michael E. Shannon, former Director General Laboratory Center for Disease Control, Health Canada.

AspeticSure is being developed in a BSL2A Certified Laboratory Located in Innovation Park, Queen's University at Kingston, Ontario, Canada. This laboratory is fully equipped to meet bio-safety level 2 laboratory standards and is dedicated exclusively to Medizone research.

The laboratory is located in the heart of one of the finest bio-medical communities and is providing a primary research and development platform for the Corporation as it proceeds down what is now a clear path to commercialization with its lead product, AsepticSure™.

This facility provides a platform for laboratory research which has the potential to expand beyond AsepticSure™.

Given the outstanding range of bactericidal kill rates we have achieved to date with the pathogens most often associated with hospital derived infections, it has become clear there are opportunities abounding to expand scientific horizons through collaborative arrangements in many diverse and exciting new applications.

About: Medizone International, Inc. is a research and development company engaged in developing its AsepticSure™ System to decontaminate and sterilize hospital surgical suites, emergency rooms, intensive care units, schools and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures.  Current research is being conducted at Medizone’s dedicated laboratories located in Innovation Park, Queen’s University in Kingston, Ontario, Canada.

Investor Relations: 972-571-1624
E-mail: operations @ medizoneint.com